Y
Yorlabs
Solves complex clinical needs in cardiac imaging through the world's most advanced, high-performance, miniaturized ultrasound technology
About Yorlabs
YorLabs, a medical device company established in 2015 by former Intel engineers Anshumali Roy and Clark Brooks, is focused on advancing intracardiac imaging technology.
The founders leverage their extensive experience in technology and engineering to address complex clinical needs in cardiac care. Roy, the company's CTO, and Brooks, the principal scientist, have deep roots in ultrasound technology, which forms the foundation of YorLabs' core product.
The company is developing a high-performance, miniaturized intracardiac echocardiography (ICE) system. This system is designed to provide real-time, high-resolution images of the heart's internal structures, aiding in the diagnosis and treatment of cardiovascular diseases. The system's key features include single-operator controls and the integration of artificial intelligence to enhance image quality and provide decision support to clinicians.
YorLabs operates in the medical device market, specifically targeting the growing field of image-guided cardiac interventions. Its primary customers are hospitals and cardiac catheterization labs. The company's business model is centered on the development and sale of its proprietary ultrasound imaging system and related software.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Beaverton, United States
- Employees
- 29
- Open positions
- None listed
- Dealroom signal
- 80.5/100
- Industry
- Health
- Sub-industry
- BioTechnology
- Sector
- Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| LATE VC✓Equity / VC | Oct 2023 | $17M | $69M | Undisclosed | ↗ |
| EARLY VCEquity / VC | Oct 2021 | $13M | $50M | Undisclosed | — |
Growth signals
Latest recorded traffic for Yorlabs is 1.8K monthly website visits, up 1185.7% over the last three months. Yorlabs's team grew 7.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Yorlabs on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Yorlabs’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.